Subsequently, western blot analysis showed that PTX3 was notably upregulated in the ovarian tissues in the OHSS group compared with the control group, which was then significantly downregulated by 16 IU and 24 IU VD3 treatment (Fig. 4B). This evidence concerns the gene PTX3 and ovarian hyperstimulation syndrome.